Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on October 14, 2026

Oct. 14, 2026

DONALD P. MAFRIGE MAKES HISTORIC $5 MILLION PLEDGE TO SKY HIGH FOR KIDS

Indeterminate EIN Presswire

Oct. 14, 2026

Lovevoo Brings a Take-Home Extra Virgin Olive Oil Experience to Pompa LIVE ’26

Indeterminate EIN Presswire

Oct. 14, 2026

Houston Emergency Physician Discusses the Role of Artificial Intelligence in Emergency Medicine

Indeterminate EIN Presswire

Oct. 14, 2026

Working Solutions Marks 30 Years with Brand Refresh and New Digital Experience

Indeterminate EIN Presswire

Oct. 14, 2026

Tylock Nasser Vision Helps Lead First-of-Its-Kind Humanitarian Refractive Surgery Mission in Cusco, Peru

Indeterminate EIN Presswire

Oct. 14, 2026

Black Horse Health Names Ruth Ann Rigby Chief Strategy Officer

Indeterminate EIN Presswire

Oct. 14, 2026

VMD Sciences Unveils VMD Access International at WSAVA 2026

Indeterminate EIN Presswire

Oct. 14, 2026

Ossium Health Data on On-Demand Organ Donor Bone Marrow Selected as a Top Poster at the 2026 AABB Annual Meeting

Indeterminate GlobeNewswire

Oct. 14, 2026

Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026

Indeterminate GlobeNewswire

Oct. 14, 2026

Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 14, 2026

Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026

Indeterminate GlobeNewswire

Oct. 14, 2026

PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026

Indeterminate GlobeNewswire

Oct. 14, 2026

Lisata Therapeutics Appoints Jeff Farrow to Board of Directors

Indeterminate GlobeNewswire

Oct. 14, 2026

Teladoc Health to Announce Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 14, 2026

Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism

Indeterminate GlobeNewswire

Oct. 14, 2026

Lakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics

Indeterminate GlobeNewswire

Oct. 14, 2026

Lakefront kondigt de verkoop aan van haar preklinische CAR-T-programma’s aan Armed Cell Therapeutics

Indeterminate GlobeNewswire

Oct. 14, 2026

MIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026

Indeterminate GlobeNewswire

Oct. 14, 2026

MannKind to Participate in the Chardan Healthcare Conference

Indeterminate GlobeNewswire

Oct. 14, 2026

Belite Bio Announces Multi-Market Submission of Marketing Authorization Applications Via the Access Consortium Pathway for Tinlarebant for the Treatment of Stargardt Disease Type 1

Indeterminate GlobeNewswire